Assessment of survival and cardiotoxicity of adjuvant trastuzumab among HER2 breast cancer patients in an oncology centre in Malaysia / Harissa H Hasbullah ... [et al.]

• Váldodahkkit: Hasbullah, Harissa H (Dahkki), Bustamam, Anita (Dahkki), Tho, Lye Munn (Dahkki), Phua, Vincent (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Universiti Teknologi MARA Cawangan Selangor, 2018-06.
• Fáttát: Article; PeerReviewed
• Liŋkkat: Link Metadata

Adjuvant trastuzumab has been used in human epidermal growth factor-2 (HER2) breast cancer to improve survival but with concern of cardiotoxicity. Our study is the first to review efficacy and toxicity of adjuvant trastuzumab in Malaysia. Methods: This is a retrospective cohort study on HER2 non met...